Olympian Clinical Research

NOVEMBER 9, 2022

Radiation therapy. Immunosuppressive therapy may also be used to treat bullous pemphigoid. This therapy uses drugs such as azathioprine to suppress your body’s immune response. Immunosuppressive therapy is typically only used when other treatments haven’t worked or your symptoms are severe.

Treatment 52

Treatment Clinical Research Immune Response Therapies 52

Olympian Clinical Research

NOVEMBER 16, 2022

HS is believed to develop due to an immune response that generates too much inflammation. People with HS may have an overactive immune system, which causes their bodies to overreact to the presence of a blocked hair follicle. Clinical Research on Hidradenitis Suppurativa. It’s also not caused by poor hygiene.

Treatment 52

Treatment Clinical Research Immune Response Therapies 52

The Pharma Data

NOVEMBER 22, 2020

We now have a pipeline of undisclosed therapeutic partnerships nearing clinical research. The experience in antibody discovery shared by FJB and IONTAS, together with their unique library of target binders, makes them ideal partners as we focus on successfully progressing these transformational therapies to patients in need.”.

Immune Response 52

Immune Response Engineering Clinical Research Disease 52

The Pharma Data

JANUARY 3, 2021

Both Jerry and Jeff have proven and successful track records in the design and execution of early and late-stage clinical trials that have evaluated novel immune therapies. The backbone of NexImmune’s approach is its proprietary Artificial Immune Modulation (AIM TM ) nanoparticle technology platform.

Immune Response 40

Immune Response Clinical Trials Therapies Cell Biology 40

The Pharma Data

NOVEMBER 9, 2020

Cancer immunotherapies such as immune checkpoint inhibitors (ICIs) have shown promising clinical outcomes over the past two decades; and they are often used for patients with advanced cancers once other therapies have reached the end of their effectiveness. NBTXR3 is injected one time, directly into solid tumors.

Immune Response 40

Immune Response Therapies Clinical Trials Treatment 40

The Pharma Data

NOVEMBER 10, 2020

We’re excited to be collaborating with Tiziana to support the development of a novel, oral therapy that could provide Crohn’s patients with another option in their repertoire of treatments to combat this devastating disease.”. Parexel is focused on supporting the development of innovative therapies to improve patient health.

Clinical Trials 40

Clinical Trials Science Disease Trials 40

Advarra

JANUARY 11, 2024

The applications of mRNA-based therapies in cancer research represent one of the next groundbreaking steps toward improved cancer treatments. While mRNA usage has played several roles in clinical research , oncology researchers in particular are eager to explore the possibilities of mRNA-based cancer vaccines.

Vaccine 52

Vaccine Therapies Clinical Trials Small Molecule 52

Olympian Clinical Research

DECEMBER 19, 2023

With ongoing research and clinical trials , institutions like Olympian Clinical Research are at the forefront of finding innovative treatment options. For more severe cases, systemic medications, including newer biologics that target immune responses, are used. What is Pediatric Plaque Psoriasis?

Clinical Research 52

Clinical Research Clinical Trials Treatment Immune Response 52

Conversations in Drug Development Trends

MARCH 12, 2024

These markers can inform treatment response and help reduce patient radiation exposure by reducing the need for repeated imaging assessments in clinical trials.

Clinical Trials 72

Clinical Trials Immune Response Trials Disease 72

The Pharma Data

JANUARY 17, 2021

The study enrolled 5,050 patients who received either vericiguat or placebo in combination with available heart failure therapies. It was co-sponsored by Merck and Bayer, conducted with the scientific oversight of the Canadian VIGOUR Centre and the Duke Clinical Research Institute.

FDA 52

FDA Small Molecule Immune Response Hospitals 52

The Pharma Data

OCTOBER 19, 2020

NBTXR3 is a novel radioenhancer composed of functionalized hafnium oxide nanoparticles that is administered via one-time intra-tumoral injection and activated by radiation therapy. The physical and universal mode of action (MoA) of NBTXR3 is designed to trigger cellular destruction death and adaptive immune response.

Clinical Trials 40

Clinical Trials Immune Response Trials Therapies 40

Drug Target Review

FEBRUARY 21, 2024

Stem cell transplants have saved patients’ lives time and time again, which led us to launch our own Stem Cell Transplant and Cellular Therapy Program. Stem cell transplants primarily help the immune response through the “graft-versus-leukaemia effect,” and we have to manage the “graft versus host effect.”

Therapies 64

Therapies Treatment Vaccine FDA Approval 64

The Pharma Data

NOVEMBER 1, 2020

This clinical trial will be coordinated by the team at the INTRIALS, a leading, full-service Latin America Clinical Research Organization (CRO), based in Sao Paulo City, Brazil. The clinical data from this trial is expected to available by the end of this year. Brazil has reported almost 5.5M

Clinical Trials 40

Clinical Trials Trials Medical Schools Hospitals 40

Vial

DECEMBER 11, 2023

In the decades since its identification in 1989, advances in clinical research for new Hepatitis C therapies and the introduction of direct-acting antiviral agents (DAAs) have led to viral eradication in more than 98% of patients, resulting in HCV crossing from manageable to being the first curable , chronic viral infection.

Clinical Research 52

Clinical Research Therapies Research Vaccine 52

Drug Target Review

DECEMBER 13, 2024

2 Unmet needs in lung cancer treatment Recent decades have seen significant advancements in lung cancer treatment, especially with the introduction of targeted therapies and immunotherapies, which have notably improved survival rates. 7 Recent clinical studies highlight promising developments in c-MET-targeting ADCs for NSCLC.

Therapies 98

Therapies Treatment Clinical Trials Drugs 98

NIH Director's Blog: Drug Development

FEBRUARY 16, 2021

This improvement stems from several factors, including the FDA’s emergency use authorization (EUA) of a number of therapies found to be safe and effective for COVID-19. ACTIV was founded last April to accelerate drug research that typically requires more than a decade of clinical ups and downs to develop a safe, effective therapy.

Clinical Trials 52

Clinical Trials Trials Hospitals Vaccine 52

The Pharma Data

APRIL 4, 2023

Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Padcev (enfortumab vedotin-ejfv) for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (la/mUC) who are not eligible for cisplatin-containing chemotherapy. in these patients.

Treatment 40

Treatment FDA Approval FDA Therapies 40

The Anticancer Fund

JUNE 23, 2023

While other regimens have shown similar promising results, the authors note that in low and middle income countries this simple and low-cost treatment may be suitable as a maintenance therapy in high-risk LGG patients. Gauthier Bouche & Pan Pantziarka Gauthier Bouche (MD) is Director of Clinical Research at the Anticancer Fund.

Drugs 52

Drugs Trials Clinical Trials Treatment 52

Conversations in Drug Development Trends

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research 59

Research Clinical Trials Therapies Immune Response 59

The Pharma Data

DECEMBER 20, 2020

The data demonstrated the vaccine elicited a combined adaptive humoral and cellular immune response and also provided insights into the composite nature of BNT162b2-induced T-cell immunity. eTrueNorth is actively recruiting COVID-19-positive patients about potential participation in the NIH’s ACTIV-2 clinical research trial.

Vaccine 52

Vaccine Trials Therapies Small Molecule 52

Broad Institute

NOVEMBER 6, 2024

Earlier this year, the researchers shared their first translational results, describing the immune cell response underlying colon inflammation in patients undergoing ICI therapy. These are home-run, breakthrough therapies, and quite an amazing success story. How did you go about launching this effort?

Research 131

Research Immune Response Hospitals Therapies 131

The Pharma Data

DECEMBER 17, 2020

“This study suggests that maybe we could predict or diagnose depression based on inflammatory scores,” said Samara Huckvale, an undergraduate at Columbia University working in the laboratory of UT Southwestern professor Sherwood Brown, senior author of both papers and professor of psychiatry and vice chair for clinical research at UTSW. “Or

Research 52

Research Hospitals Clinical Trials Immune Response 52

Codon

OCTOBER 27, 2024

Today, scientists would halt clinical research on drugs with these properties, but back then, many researchers put stock in the “magic bullet” theory proposed by Paul Ehrlich , a German biologist. Interferon gamma release assays pick up an immune response to the infection. A sputum test stain for M.

Immune Response 99

Immune Response Doctors Disease Laboratories 99